Quantcast

Latest Gynecologic oncology Stories

2010-07-06 13:15:02

Discovery provides new hope to cancer patients with few treatment options Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy. A scientific paper that will be published in the September issue of the journal Gynecologic Oncology describes how the inhibition of a protein, CHEK1, may be an effective element to incorporate into therapies for women with ovarian cancer....

2010-06-22 12:22:00

IRVINE, Calif., June 22 /PRNewswire/ -- OvaGene Oncology Inc., a biotechnology company specializing in the development and commercialization of personalized DNA-based diagnostics for gynecologic cancer, announced today the opening of its new clinical and research laboratory in Irvine, California. This state-of-the-art facility will serve as the central headquarters for operations, research, and molecular clinical lab testing. The opening of the laboratory is an important first step for...

2010-06-22 11:00:00

New Survey Offers Data Updates into Practice Patterns, Compensation and Demographics of Gynecologic Oncologists and the State of Women's Cancer Care CHICAGO, June 22 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO), the country's leading organization of board certified women's cancer specialists, is now offering the results of its member-based, demographic and practice survey: "Gynecologic Oncology 2010: State of the Subspecialty." The comprehensive survey takes an...

2010-06-08 11:08:00

Further initiatives are recommended to promote uptake of prophylactic HPV vaccination that target high-risk women before existing disparities widen CHICAGO, June 8 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has published its third in a series of four papers on a variety of cervical cancer issues and topics featured at "The Future Strategies for Cervical Cancer Prevention: What Do We Need to Do Now to Prepare" Forum. The paper, entitled "Can the Barriers to HPV...

2010-06-07 14:34:00

HACKENSACK, N.J., June 7 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center announced today the addition of Ami Vaidya, M.D. to the division of gynecologic oncology. Dr. Vaidya is dual-board certified in gynecologic-oncology and obstetrics-gynecology. She brings a world-class education and more than seven years of gynecology experience to the cancer center. "We are thrilled to have Dr. Vaidya join our expert gynecologic oncology team," said Andrew L....

2010-06-06 11:30:00

CHICAGO, June 6 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian cancer. A total of 68 patients were enrolled with platinum-resistant disease, half of whom were platinum refractory. All 68 patients were evaluable for the primary endpoint of objective response rate using Gynecologic Cancer InterGroup (GCIG) criteria, which is a...

2010-05-18 11:00:00

Updated Survey Data Offers Insights into Practice Patterns, Compensation and Demographics of Gynecologic Oncologists and the State of Women's Cancer Care CHICAGO, May 18 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO), the country's leading organization of board certified women's cancer specialists, has just released the results of a member-based, demographic and practice survey: "Gynecologic Oncology 2010: State of the Subspecialty." The comprehensive survey takes...

2010-05-17 06:30:00

QUEBEC CITY, May 17 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), (the "Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for its compound AEZS-108 for the treatment of ovarian cancer. AEZS-108, the Company's doxorubicin targeted conjugate...

2010-05-06 06:30:00

QUEBEC CITY, May 6 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in...

868e989ecf796d04c1b96b7fb2eb74d21
2010-05-04 15:48:05

In the race to find answers about ovarian cancer, researchers now have something to cluck about. For five years, University of Illinois researchers have been using the chicken as a model to study this deadly disease and have recently discovered that a diet enriched with flaxseed decreases severity of ovarian cancer and increases survival in hens. Flaxseed is the richest plant source of alpha-linolenic acid, one type of omega-3 fatty acid. Several studies have already shown that flaxseed...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related